S

Sun Pharma Advanced Research Co Ltd
NSE:SPARC

Watchlist Manager
Sun Pharma Advanced Research Co Ltd
NSE:SPARC
Watchlist
Price: 135.23 INR 0.91% Market Closed
Market Cap: 43.9B INR

Wall Street
Price Targets

SPARC Price Targets Summary
Sun Pharma Advanced Research Co Ltd

There are no price targets for SPARC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Sun Pharma Advanced Research Co Ltd Competitors:
Price Targets
ETON
Eton Pharmaceuticals Inc
85% Upside
VETO
Vetoquinol SA
11% Upside
EAH
ECO Animal Health Group PLC
99% Upside
MVP
Medical Developments International Ltd
65% Upside
128940
Hanmi Pharm Co Ltd
12% Upside

Revenue
Forecast

Revenue Estimate
Sun Pharma Advanced Research Co Ltd

For the last 13 years the compound annual growth rate for Sun Pharma Advanced Research Co Ltd's revenue is 7%. The projected CAGR for the next 2 years is 2 961%.

7%
Past Growth
2 961%
Estimated Growth
Estimates Accuracy
-100%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sun Pharma Advanced Research Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Sun Pharma Advanced Research Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SPARC's stock price target?
Not Available

SPARC doesn't have any price targets made by Wall Street professionals.

What is Sun Pharma Advanced Research Co Ltd's Revenue forecast?
Projected CAGR
2 961%

For the last 13 years the compound annual growth rate for Sun Pharma Advanced Research Co Ltd's revenue is 7%. The projected CAGR for the next 2 years is 2 961%.

Back to Top